The global Point-of-Care Infectious Disease Diagnostics market size in 2023 is 4658.7 million US dollars, and it is expected to be 12851.9 million US dollars by 2030, with a compound annual growth rate of 15.6% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Point-of-Care Infectious Disease Diagnostics market include Danaher Corporation, Alcon Laboratories, Inc., Abbott Laboratories, Hoffman- La Roche Ltd, and Becton, Dickinson and Company. The share of the top 3 players in the Point-of-Care Infectious Disease Diagnostics market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Point-of-Care Infectious Disease Diagnostics market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Lateral Flow accounted for XX% of Point-of-Care Infectious Disease Diagnostics market in 2023. Agglutination Assays share of XX%.
Hospital accounted for XX% of the Point-of-Care Infectious Disease Diagnostics market in 2023. Diagnostic Laboratories accounts for XX%.
This Point-of-Care Infectious Disease Diagnostics market report provides detailed information on latest developments, trade regulations, value chain optimization, market share, impact of domestic and local market players, analyzes emerging revenue sources, market regulation changes Opportunities in Aspects, Strategic Market Growth Analysis, Market Size, Category Market Growth, Application Areas and Dominance, Product Approvals, Product Launches, Geographic Expansion, Technological Innovations in the Market.
Point-of-Care Infectious Disease Diagnostics market country level analysis
The countries covered in the Point-of-Care Infectious Disease Diagnostics market report include the United States, Canada, Germany, United Kingdom, France, Russia, Japan, China, India, South Korea, Brazil, UAE, Saudi Arabia, etc.
The presence and availability of global brands and challenges due to intense or scarce competition from local and domestic brands, and trade routes are also considered while providing the predictive analysis of country data.
Competitive Landscape and Point-of-Care Infectious Disease Diagnostics Market Share Analysis
Point-of-Care Infectious Disease Diagnostics market competitive landscape provides details by competitors. The detailed information includes company profile, company financials, revenue generated, market potential, R&D investments, new market plans, global reach. The data points presented above relate only to companies relevant to the Point-of-Care Infectious Disease Diagnostics market.
Chapter Outline
Chapter 1: Introduces the product overview, market scope, economic analysis of global regions, and industry dynamic analysis, and then includes inflation analysis, the impact of the Russo-Ukrainian war on the market, and the global impact of the coronavirus disease (COVID-19).
Chapter 2: Analyzes the main companies in the Point-of-Care Infectious Disease Diagnostics industry, including their main businesses, products/services, revenue, gross margin, and SWOT Analysis.
Chapter 3: Analysis of the competitive environment of Point-of-Care Infectious Disease Diagnostics market participants. This mainly includes the revenue and market share of the top players, along with the players” M&A and new entrants and expansion plans.
Chapters 4-6: Segmented the global Point-of-Care Infectious Disease Diagnostics market by type, application and region. Analyze the revenue of market segments from different perspectives.
Chapters 7-11: Provide North America, Europe, Asia-Pacific, Latin America and Middle East & Africa Point-of-Care Infectious Disease Diagnostics market type, application, country and player market segmentation data, and include SWOT Analysis.
Chapter 12: Analyzes the Point-of-Care Infectious Disease Diagnostics business cost, including industrial chain and the proportion of business cost structure.
Chapter 13: The main points and conclusions of the report.
Chapter 14: Concludes with an explanation of the data sources and research methods.
Highlights-Regions
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
South America
Brazil
Argentina
MEA
Saudi Arabia
Egypt
Turkey
UAE
South Africa
Player list
Danaher Corporation
Alcon Laboratories, Inc.
Abbott Laboratories
Hoffman- La Roche Ltd
Becton, Dickinson and Company
Trinity Biotech Plc
Cardinal Health Inc.
Types list
Lateral Flow
Agglutination Assays
Flow Through
Solid Phase
Application list
Hospital
Diagnostic Laboratories
Home-care settings
Others
Table of Content
1 Market Overview
1.1 Point-of-Care Infectious Disease Diagnostics Introduction
1.2 Market Analysis by Types
1.3 Market Analysis by Applications
1.4 Global Point-of-Care Infectious Disease Diagnostics Market Size & Forecast
1.4.1 Global Point-of-Care Infectious Disease Diagnostics Revenue (2019 VS 2023 VS 2030)
1.4.2 Global Point-of-Care Infectious Disease Diagnostics Revenue in Value (2019-2030)
1.5 Market Drivers, Restraints and Trends
1.5.1 Point-of-Care Infectious Disease Diagnostics Market Drivers
1.5.2 Point-of-Care Infectious Disease Diagnostics Market Restraints
1.5.3 Point-of-Care Infectious Disease Diagnostics Trends Analysis
1.6 Economic Analysis of Global Regions
1.7 Inflation Analysis
1.8 The Impact of the Russian-Ukrainian War on the Market
1.9 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Manufacturers Profiles
2.1 Danaher Corporation
2.1.1 Business Overview
2.1.2 Danaher Corporation SWOT Analysis
2.1.3 Danaher Corporation Point-of-Care Infectious Disease Diagnostics Products and Service Offered
2.1.4 Danaher Corporation Point-of-Care Infectious Disease Diagnostics Revenue and Gross Margin
2.2 Alcon Laboratories, Inc.
2.2.1 Business Overview
2.2.2 Alcon Laboratories, Inc. SWOT Analysis
2.2.3 Alcon Laboratories, Inc. Point-of-Care Infectious Disease Diagnostics Products and Service Offered
2.2.4 Alcon Laboratories, Inc. Point-of-Care Infectious Disease Diagnostics Revenue and Gross Margin
2.3 Abbott Laboratories
2.3.1 Business Overview
2.3.2 Abbott Laboratories SWOT Analysis
2.3.3 Abbott Laboratories Point-of-Care Infectious Disease Diagnostics Products and Service Offered
2.3.4 Abbott Laboratories Point-of-Care Infectious Disease Diagnostics Revenue and Gross Margin
2.4 Hoffman- La Roche Ltd
2.4.1 Business Overview
2.4.2 Hoffman- La Roche Ltd SWOT Analysis
2.4.3 Hoffman- La Roche Ltd Point-of-Care Infectious Disease Diagnostics Products and Service Offered
2.4.4 Hoffman- La Roche Ltd Point-of-Care Infectious Disease Diagnostics Revenue and Gross Margin
2.5 Becton, Dickinson and Company
2.5.1 Business Overview
2.5.2 Becton, Dickinson and Company SWOT Analysis
2.5.3 Becton, Dickinson and Company Point-of-Care Infectious Disease Diagnostics Products and Service Offered
2.5.4 Becton, Dickinson and Company Point-of-Care Infectious Disease Diagnostics Revenue and Gross Margin
2.6 Trinity Biotech Plc
2.6.1 Business Overview
2.6.2 Trinity Biotech Plc SWOT Analysis
2.6.3 Trinity Biotech Plc Point-of-Care Infectious Disease Diagnostics Products and Service Offered
2.6.4 Trinity Biotech Plc Point-of-Care Infectious Disease Diagnostics Revenue and Gross Margin
2.7 Cardinal Health Inc.
2.7.1 Business Overview
2.7.2 Cardinal Health Inc. SWOT Analysis
2.7.3 Cardinal Health Inc. Point-of-Care Infectious Disease Diagnostics Products and Service Offered
2.7.4 Cardinal Health Inc. Point-of-Care Infectious Disease Diagnostics Revenue and Gross Margin
3 Global Point-of-Care Infectious Disease Diagnostics Market Competition, by Manufacturer
3.1 Global Point-of-Care Infectious Disease Diagnostics Revenue and Market Share by Manufacturer
3.2 Market Concentration Rate
3.2.1 Top 3 Point-of-Care Infectious Disease Diagnostics Players Market Share in 2023
3.2.2 Top 6 Point-of-Care Infectious Disease Diagnostics Players Market Share in 2023
3.2.3 Market Competition Trend
3.3 Point-of-Care Infectious Disease Diagnostics Players Head Office, Business Provided
3.4 Point-of-Care Infectious Disease Diagnostics Mergers & Acquisitions
3.5 Point-of-Care Infectious Disease Diagnostics New Entrants and Expansion Plans
4 Market Segment by Type
4.1 Global Point-of-Care Infectious Disease Diagnostics Revenue in Value by Type (2019-2030)
4.2 Global Point-of-Care Infectious Disease Diagnostics Revenue Share by Type (2019-2030)
5 Market Segment by Application
5.1 Global Point-of-Care Infectious Disease Diagnostics Revenue by Application (2019-2030)
5.2 Global Point-of-Care Infectious Disease Diagnostics Revenue Share by Application (2019-2030)
6 Global Point-of-Care Infectious Disease Diagnostics Market Analysis by Regions
6.1 Global Point-of-Care Infectious Disease Diagnostics Revenue and Market Share by Regions
6.1.1 Global Point-of-Care Infectious Disease Diagnostics Revenue by Regions (2019-2030)
6.1.2 Global Point-of-Care Infectious Disease Diagnostics Revenue Market Share by Regions (2019-2030)
6.2 North America Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
6.3 Europe Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
6.4 Asia Pacific Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
6.5 South America Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
6.6 Middle East and Africa Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
7 North America Point-of-Care Infectious Disease Diagnostics by Country, by Type, and by Application
7.1 North America Point-of-Care Infectious Disease Diagnostics Revenue by Type (2019-2030)
7.2 North America Point-of-Care Infectious Disease Diagnostics Revenue by Application (2019-2030)
7.3 North America Point-of-Care Infectious Disease Diagnostics Revenue and Market Share by Countries
7.3.1 North America Point-of-Care Infectious Disease Diagnostics Revenue in Value by Country (2019-2030)
7.3.2 United States Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
7.3.3 Canada Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
7.3.4 Mexico Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
7.4 North America SWOT Analysis
8 Europe Point-of-Care Infectious Disease Diagnostics by Country, by Type, and by Application
8.1 Europe Point-of-Care Infectious Disease Diagnostics Revenue by Type (2019-2030)
8.2 Europe Point-of-Care Infectious Disease Diagnostics Revenue by Application (2019-2030)
8.3 Europe Point-of-Care Infectious Disease Diagnostics Revenue and Market Share by Countries
8.3.1 Europe Point-of-Care Infectious Disease Diagnostics Revenue in Value by Country (2019-2030)
8.3.2 Germany Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
8.3.3 France Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
8.3.4 United Kingdom Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
8.3.5 Russia Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
8.3.6 Italy Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
8.3.7 Nordic Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
8.4 Europe SWOT Analysis
9 Asia Pacific Point-of-Care Infectious Disease Diagnostics by Country, by Type, and by Application
9.1 Asia Pacific Point-of-Care Infectious Disease Diagnostics Revenue by Type (2019-2030)
9.2 Asia Pacific Point-of-Care Infectious Disease Diagnostics Revenue by Application (2019-2030)
9.3 Asia Pacific Point-of-Care Infectious Disease Diagnostics Revenue and Market Share by Countries
9.3.1 Asia Pacific Point-of-Care Infectious Disease Diagnostics Revenue in Value by Country (2019-2030)
9.3.2 China Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
9.3.3 Japan Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
9.3.4 Korea Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
9.3.5 India Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
9.3.6 Southeast Asia Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
9.3.7 Australia Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
9.4 Asia Pacific SWOT Analysis
10 South America Point-of-Care Infectious Disease Diagnostics by Country, by Type, and by Application
10.1 South America Point-of-Care Infectious Disease Diagnostics Revenue by Type (2019-2030)
10.2 South America Point-of-Care Infectious Disease Diagnostics Revenue by Application (2019-2030)
10.3 South America Point-of-Care Infectious Disease Diagnostics Revenue and Market Share by Countries
10.3.1 South America Point-of-Care Infectious Disease Diagnostics Revenue in Value by Country (2019-2030)
10.3.2 Brazil Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
10.3.3 Argentina Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
10.4 South America SWOT Analysis
11 Middle East & Africa Point-of-Care Infectious Disease Diagnostics by Country, by Type, and by Application
11.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics Revenue by Type (2019-2030)
11.2 Middle East & Africa Point-of-Care Infectious Disease Diagnostics Revenue by Application (2019-2030)
11.3 Middle East & Africa Point-of-Care Infectious Disease Diagnostics Revenue and Market Share by Countries
11.3.1 Middle East & Africa Point-of-Care Infectious Disease Diagnostics Revenue in Value by Country (2019-2030)
11.3.2 Turkey Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
11.3.3 Egypt Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
11.3.4 Saudi Arabia Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
11.3.5 UAE Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
11.3.6 South Africa Point-of-Care Infectious Disease Diagnostics Revenue and Growth (2019-2030)
11.4 Middle East and Africa SWOT Analysis
12 Point-of-Care Infectious Disease Diagnostics Business Cost Analysis
12.1 Proportion of Business Cost Structure
12.1.1 Labor Cost
12.1.2 Operating Expenses
12.2 Point-of-Care Infectious Disease Diagnostics Industrial Chain Analysis
13 Research Findings and Conclusion
14 Methodology and Data Source
14.1 A Methodology
14.1.1 Research Process
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 B Data Source
14.2.1 Legal Disclaimer